SYNVISC®

Administering Techniques

SYNVISC® is injected directly into the intra-articular space of the knee by a qualified medical professional. The injection technique depends on the patient’s anatomy and the specific product being used.

• Joint aspiration may be performed prior to injection 
• Sterile technique is essential to minimize infection risk 
• Post-procedure, patients should limit activity for 24–48 hours 

Depending on the product format, either a single injection or a 3-injection series is recommended.

SYNVISC® Product Range

• SYNVISC® 2 mL Syringe: A three-injection regimen with 16 mg/mL of hylan G-F 20 to be administered at weekly intervals for sustained relief. 
• SYNVISC ONE® 6 mL Syringe: A single-injection format providing the full treatment dose in one session, offering convenience for both provider and patient. 

Each SYNVISC product is prefilled and ready for use under sterile conditions.

Side Effects

SYNVISC® is associated with minimal side effects, which are typically localized and resolve within a few days:

• Mild swelling or discomfort at the injection site 
• Temporary joint stiffness 
• Occasional warmth or redness in the injected knee 

Serious reactions are rare and largely avoidable with proper patient selection and sterile administration.

SYNVISC® vs Competition

Compared to other viscosupplements, SYNVISC® delivers a unique combination of viscosity, cushioning, and extended durability thanks to its proprietary hylan polymer formulation. While products like MONOVISC® and SUPARTZ® are effective, SYNVISC® provides both multi-dose and single-dose formats, offering flexibility for treatment planning.

Clinicians seeking to order SYNVISC ONE online benefit from simplified administration without compromising therapeutic outcome. Whether in single or three-dose formats, SYNVISC® remains a leading viscosupplement trusted by orthopedic professionals worldwide.